vFLIP and vCyclin decrease SMAD2 protein expression and desensitize TGF-β signaling. by Hong Seok Choi (121525)

“…<p>(A) SMAD2 expression was drastically decreased upon the expression of vFLIP or vCyclin in SLK cells. …”

Antibody responses and FRT pathology are comparable between WT and <i>Bhlhe40</i>^<i>-/-</i> mice. by Miguel A. B. Mercado (17847533)

GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

“…<p>(<b>A,B</b>) Representative TEVC recordings obtained from oocytes expressing WT GluN1/GluN2A (WT 2A) receptors (<b>A</b>) and GluN1/GluN2A(D731N) (2A-D731N) receptors (<b>B</b>) in which the currents were evoked by increasing concentrations (μM) of glutamate (in the presence of 100 μM glycine) at the holding potential of -40 mV. …”

Decreased type 1 IFN and enhanced MHV-68 loads in lungs of TLR2- and MyD88-deficient mice. by François Michaud (360245)

Decreased cell integrity and an increased number of intracellular membrane compartments in <i>ap1b1</i> mutant HCs. by Rachel Clemens Grisham (402043)

Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio by Jani Luukkonen (4339744)

“…The TRAcP 5B/5A ratio was decreased in RA and correlated negatively with the amount of phospho-OPN (p<0.05). …”

Loss of SRC-2 results in decreased expression of several cardiac transcription factors important for controlling metabolic and sarcomeric gene expression. by Erin L. Reineke (107382)

LS-PGC-1β^−/− mice exhibit decreased expression of TCA and ETC enzymes and mtDNA content. by Kari T. Chambers (106919)

Enhanced Nrf2 activity decreases fatty acid transport and results in increased fatty acids content in white adipose tissue. by Jialin Xu (40952)

S1/2^-/- mice display novelty induced hyperactivity, decreased anxiety and exploratory behavior and working memory disturbances. by Paul C. Baier (650225)

“…WT: n = 24, S1/2^-/-: n = 26. A) Novelty-induced hyperactivity in S1/2^-/- mice as assessed by moving distance in the open field (p_MW = 0.0006). …”

APB5, but not APA5, decreases apoptosis in alveolar epithelial cells in lungs of BLM-treated mice. by Masami Kishi (6167105)

“…The administration of APA5 did not change the number of TUNEL-positive cells from that in BLM-treated mice, whereas that of APB5 significantly decreased them. …”

Impaired glucose metabolism and decreased insulin sensitivity in isolated adipocytes of Nscl-2−/−, Nscl-2−/−×ob/ob mice and controls. by Karen Ruschke (372824)

HC-070 decreases anxiety after CCK-4 treatment in an EPM. by Stefan Just (4811358)

Figure S1 - VILIP-1 Expression <em>In Vivo</em> Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development by Jian Fu (41067)

<i>Cdkl5</i> -/Y mice show an increased freezing time and a decreased distance traveled during the pretone period in the altered context. by Kosuke Okuda (5150393)

“…<i>Cdkl5</i> -/Y mice show a significantly decreased distance traveled in response to the first footshock (p = 0.0158) compared with control mice. …”

c1 dKI mice have decreased CD4, T_fh, and IFNγ-producing T cells. by Kieran P. Manion (9179139)

Decreased phosphorylation of GSK3β-Ser9 in thrombin stimulated PP1cγ^−/− platelets. by Francisca C. Gushiken (368549)

“…Data are expressed as ±SEM of 5 experiments. (<b>D</b>) Effect of GSK3β inhibitor VIII on thrombin-induced fibrinogen binding on WT and PP1cγ^−/− platelets. …”

zQ175 mice displayed progressive motor deficits on balance beam and decreased locomotor activity in the Open Field chambers. by Qi Peng (702503)

a-c: Proximal tibia (PT) EPO receptor (EPO-R) decreases in uremic rats, as shown by Western blot (Fig. 5a) and immunohistochemistry (Fig. 5b). by Daniel Landau (440830)

“…Animals received a single bolus of IV rhEPO (25 U/kg) or saline, 5 minutes prior to sacrifice. …”

Blocking VIP-signaling increased expression of costimulatory molecules and decreased expression of coinhibitory molecules on lymphocytes following mCMV infection. by Jian-Ming Li (319425)